Please login to the form below
16
Revenue 2017Tecfidera
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tecfidera was produced by Biogen Idec.
Spinraza lifts Biogen ahead of Alzheimer’s data
Along with a useful contribution from biosimilars, that cushioned the impact of flat sales for Biogen’s multiple sclerosis franchise, headed by Tecfidera (dimethyl fumarate), which has been hit by competition ... MS drug sales came in at $2.3bn, with
Dismay as NICE rejects Roche’s MS drug Ocrevus
such as Novartis’Gilenya (fingolimod) and Biogen’s Tecfidera (dimethyl fumarate).
The good, the bad and the ugly
Tecfidera (MS) and Spinraza (Spinal Muscular Atrophy) are expected to generate big sales, while Tysabril (MS and Crohn’s Disease) and Avonex (MS) are expected to see sales drop due to
Biogen cuts $217m deal for Karyopharm neurology drug
Biogen reported 2017 revenues of $12.3bn, up 15% on the prior year, thanks to gains for its multiple sclerosis drugs, particularly Tecfidera (dimethyl fumarate) and rising royalties from Ocrevus (ocrelizumab) -
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Account Manager- Healthcare Advertising
-
Negotiable
- Business Development Director – Health Education
-
excellent commission
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Principal Health Economist - North-West
-
Negotiable
-
Account Director
-
Competitive Salary Offered
- Account Manager- Healthcare Advertising
-
Negotiable
-
Business Director
-
Competitive Salary Offered
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Senior Account Manager
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
Subscribe to our email news alerts
- Beneluxa: the future of European market access?
- Fishawack acquires Blue Latitude Health
- FDA clears Sandoz and Pear’s Opioid Use Disorder app
- As May delays, industry warns again of ‘no-deal’ Brexit
- Clark Health Communications and Egg digital announce new collaboration
- Axovant drops last ‘legacy’ drug to focus on gene therapies
PMHub
GK Strategy
GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
